B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

LYPLA2

MOLECULAR TARGET

lysophospholipase 2

UniProt: O95372NCBI Gene: 113132 compounds

LYPLA2 (lysophospholipase 2) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting LYPLA2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1molibresib3.8144
2palmostatin b1.393

About LYPLA2 as a Drug Target

LYPLA2 (lysophospholipase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented LYPLA2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

LYPLA2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.